Tag: elbasvir

March 15, 2016 Off

FDA Approves ZEPATIER for the Treatment of Chronic Hepatitis C Infection

On January 28, 2016, the United States Food and Drug Administration (FDA) approved Zepatier (elbasvir and grazoprevir) for the treatment of chronic genotype 1 or 4 hepatitis C virus (HCV) infection in adults.

October 6, 2015 Off

Merck: Results of Phase 3 Study of Investigational Chronic Hepatitis C Therapy

By Dino Mustafić

Merck has announced the publication of results from C-SURFER, the first Phase 31 clinical trial to investigate an all-oral, ribavirin-free chronic hepatitis C virus (HCV) treatment regimen in treatment-naïve and treatment-experienced patients with advanced chronic kidney disease (CKD) stages 4 or 5 and chronic HCV genotype 1 (GT1) infection.